Evidence map›Paper›PMID 37035460›Full record

ArticleAlzheimer's & dementia (Amsterdam, Netherlands)

Differential involvement of hippocampal subfields in the relationship between Alzheimer's pathology and memory interference in older adults.

Jenna N Adams, Freddie Márquez, Myra S Larson, John T Janecek, Blake A Miranda, Jessica A Noche, Lisa Taylor, Martina K Hollearn, Liv McMillan, David B Keator and 3 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Alzheimer's & dementia (Amsterdam, Netherlands). The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03860857 (The BEACoN Study- Biomarker Exploration in Aging, Cognition and Neurodegeneration), which is not on this map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03860857 phase3recruitingnot on this map

The BEACoN Study- Biomarker Exploration in Aging, Cognition and Neurodegeneration

TypeinterventionalSponsorUniversity of California, IrvineRan2018 to 2027Enrolled300ConditionsAlzheimer Disease, Cognitive Impairment, Cognitive DeclineArmsAmyloid PET scan, Tau PET scan using MK-6240, Neurocognitive testing, MRI
3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 11 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Amyloid-Beta Deposition in Basal Frontotemporal Cortex Is Associated with Selective Disruption of Temporal Mnemonic Discrimination.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Jenna N AdamsDepartment of Neurobiology and Behavior and Center for the Neurobiology of Learning and Memory University of California Irvine California USA.ORCID https://orcid.org/0000-0002-6702-3851
Freddie MárquezDepartment of Neurobiology and Behavior and Center for the Neurobiology of Learning and Memory University of California Irvine California USA.
Myra S LarsonDepartment of Neurobiology and Behavior and Center for the Neurobiology of Learning and Memory University of California Irvine California USA.
John T JanecekDepartment of Neurobiology and Behavior and Center for the Neurobiology of Learning and Memory University of California Irvine California USA.
Blake A MirandaDepartment of Neurobiology and Behavior and Center for the Neurobiology of Learning and Memory University of California Irvine California USA.
Jessica A NocheDepartment of Neurobiology and Behavior and Center for the Neurobiology of Learning and Memory University of California Irvine California USA.
Lisa TaylorDepartment of Psychiatry and Human Behavior University of California Irvine California USA.
Martina K HollearnDepartment of Neurobiology and Behavior and Center for the Neurobiology of Learning and Memory University of California Irvine California USA.
Liv McMillanDepartment of Neurobiology and Behavior and Center for the Neurobiology of Learning and Memory University of California Irvine California USA.
David B KeatorDepartment of Psychiatry and Human Behavior University of California Irvine California USA.
Elizabeth HeadDepartment of Pathology and Laboratory Medicine University of California Irvine California USA.
Robert A RissmanDepartment of Neurosciences University of California San Diego California USA.
Michael A YassaDepartment of Neurobiology and Behavior and Center for the Neurobiology of Learning and Memory University of California Irvine California USA.
University of California, Irvine · USUniversity of California San Diego · USUniversity of Kentucky · US

Funding

The Alzheimer's Clinical Trial Consortium - Down Syndrome Network (ACTC- DSN)U24AG057437 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Paul S. Aisen, RONALD C PETERSEN · 2018 to 2026
$198.4M
TRIAL OF VALPROATE TO ATTENUATE THE PROGRESSION OF ADU01AG010483 · NIA · UNIVERSITY OF ROCHESTER · PI AISEN, PAUL S. · 1991 to 2012
$116.2M
UC Irvine Alzheimer's Disease Research Center Induced Pluripotent Stem Cell CoreP50AG016573 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI LAFERLA, FRANK M · 2000 to 2019
$37.0M
UCSD Shiley-Marcos Alzheimer's Disease Research Center P30P30AG062429 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Subhojit Roy · 2019 to 2026
$34.9M
USCADRC Diversity Supplement PachicanoP30AG066530 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI HELENA Chang CHUI, ARTHUR W TOGA · 2020 to 2026
$27.8M
Neuroimaging biomarkers for cognitive decline in elderly with amyloid pathologyR01AG053555 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI Michael A Yassa · 2017 to 2026
$17.0M
Proinflammatory Endophenotype to predict NSAID treatment response Alzheimer's trialsR01AG051848 · NIA · UNIVERSITY OF NORTH TEXAS HLTH SCI CTR · PI LYKETSOS, CONSTANTINE G, O'BRYANT, SID E · 2016 to 2020
$3.7M
A Blood Test for Screening Into Alzheimer's Prevention TrialsR01AG058252 · NIA · UNIVERSITY OF NORTH TEXAS HLTH SCI CTR · PI O'BRYANT, SID E, RISSMAN, ROBERT · 2017 to 2021
$3.2M
Precision Medicine for Inflammatory Treatment for Alzheimer's Disease in Down SyndromeRF1AG073979 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI RAFII, MICHAEL S, RISSMAN, ROBERT · 2021 to 2022
$2.6M
Effect of hippocampal tau pathology on CA1 function and memory processing in agingF32AG074621 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI ADAMS, JENNA NICOLE · 2021 to 2023
$202k
NIA NIH HHS F32 AG074621NIA NIH HHS P30 AG062429NIA NIH HHS P30 AG066530NIA NIH HHS P50 AG016573NIA NIH HHS R01 AG051848NIA NIH HHS R01 AG053555NIA NIH HHS R01 AG058252NIA NIH HHS RF1 AG073979NIA NIH HHS U01 AG010483NIA NIH HHS U24 AG057437
6 · The paper itself

Abstract

Introduction: We tested whether Alzheimer's disease (AD) pathology predicts memory deficits in non-demented older adults through its effects on medial temporal lobe (MTL) subregional volume. Methods: Thirty-two, non-demented older adults with cerebrospinal fluid (CSF) (amyloid-beta [Aβ] Results: Biomarkers of AD pathology were related to RI. Dentate gyrus (DG) and CA3 volume were uniquely associated with RI, whereas CA1 and BA35 volume were related to both RI and overall memory recall. AD pathology was associated with reduced BA35, CA1, and subiculum volume. DG volume and Aβ were independently associated with RI, whereas CA1 volume mediated the relationship between AD pathology and RI. Discussion: Integrity of distinct hippocampal subfields demonstrate differential relationships with pathology and memory function, indicating specificity in vulnerability and contribution to different memory processes.

Indexed as

Alzheimer's diseaseamyloid‐betamedial temporal lobememoryneurodegenerationtau

Identifiers

PMID37035460
PMCPMC10075195
OpenAlexW4362607023

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.